EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document C:2011:008:FULL
Official Journal of the European Union, C 8, 13 January 2011
Official Journal of the European Union, C 8, 13 January 2011
Official Journal of the European Union, C 8, 13 January 2011
Display all documents published in this Official Journal
|
ISSN 1725-2423 doi:10.3000/17252423.C_2011.008.eng |
||
|
Official Journal of the European Union |
C 8 |
|
|
||
|
English edition |
Information and Notices |
Volume 54 |
|
Notice No |
Contents |
page |
|
|
II Information |
|
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
|
European Commission |
|
|
2011/C 008/01 |
Non-opposition to a notified concentration (Case COMP/M.5964 — TPV/Philips Branded Monitors and Colour TVS) ( 1 ) |
|
|
2011/C 008/02 |
Non-opposition to a notified concentration (Case COMP/M.6052 — London & Continental Railways/Lend Lease Europe/Stratford City Business District) ( 1 ) |
|
|
2011/C 008/03 |
Non-opposition to a notified concentration (Case COMP/M.5908 — Honeywell/Sperian) ( 1 ) |
|
|
2011/C 008/04 |
Communication from the Commission upon full use of the abatimento quota for 2010 (maize, Portugal) |
|
|
|
IV Notices |
|
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
|
European Commission |
|
|
2011/C 008/05 |
||
|
|
NOTICES FROM MEMBER STATES |
|
|
2011/C 008/06 |
||
|
|
NOTICES CONCERNING THE EUROPEAN ECONOMIC AREA |
|
|
|
Standing Committee of the EFTA States |
|
|
2011/C 008/07 |
||
|
|
V Announcements |
|
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
|
European Commission |
|
|
2011/C 008/08 |
Initiation of proceedings (Case COMP/M.5907 — Votorantim/Fischer/JV) ( 1 ) |
|
|
|
|
|
|
(1) Text with EEA relevance |
|
EN |
|
II Information
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
|
13.1.2011 |
EN |
Official Journal of the European Union |
C 8/1 |
Non-opposition to a notified concentration
(Case COMP/M.5964 — TPV/Philips Branded Monitors and Colour TVS)
(Text with EEA relevance)
2011/C 8/01
On 9 November 2010, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
|
— |
in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
|
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32010M5964. EUR-Lex is the on-line access to the European law. |
|
13.1.2011 |
EN |
Official Journal of the European Union |
C 8/1 |
Non-opposition to a notified concentration
(Case COMP/M.6052 — London & Continental Railways/Lend Lease Europe/Stratford City Business District)
(Text with EEA relevance)
2011/C 8/02
On 7 January 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
|
— |
in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
|
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6052. EUR-Lex is the on-line access to the European law. |
|
13.1.2011 |
EN |
Official Journal of the European Union |
C 8/2 |
Non-opposition to a notified concentration
(Case COMP/M.5908 — Honeywell/Sperian)
(Text with EEA relevance)
2011/C 8/03
On 4 August 2010, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:
|
— |
in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
|
— |
in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32010M5908. EUR-Lex is the on-line access to the European law. |
|
13.1.2011 |
EN |
Official Journal of the European Union |
C 8/2 |
Communication from the Commission upon full use of the ‘abatimento’ quota for 2010 (maize, Portugal)
2011/C 8/04
Commission Regulation (EU) No 1262/2010 (1) provides for the prolongation of the 2010 quota tenders for import from third countries, for release for free circulation in Portugal, of 500 000 tonnes of maize, until the quota is completely used and at the latest until 31 May 2011. As on Tuesday 14 December 2010 the quantity of the 2010 quota has been completely used, imports from 1 January 2011 shall count towards the 2011 quota.
(1) OJ L 343, 29.12.2010, p. 76.
IV Notices
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES
European Commission
|
13.1.2011 |
EN |
Official Journal of the European Union |
C 8/3 |
Euro exchange rates (1)
12 January 2011
2011/C 8/05
1 euro =
|
|
Currency |
Exchange rate |
|
USD |
US dollar |
1,2973 |
|
JPY |
Japanese yen |
108,17 |
|
DKK |
Danish krone |
7,4496 |
|
GBP |
Pound sterling |
0,83155 |
|
SEK |
Swedish krona |
8,8435 |
|
CHF |
Swiss franc |
1,2622 |
|
ISK |
Iceland króna |
|
|
NOK |
Norwegian krone |
7,7060 |
|
BGN |
Bulgarian lev |
1,9558 |
|
CZK |
Czech koruna |
24,390 |
|
HUF |
Hungarian forint |
275,57 |
|
LTL |
Lithuanian litas |
3,4528 |
|
LVL |
Latvian lats |
0,7009 |
|
PLN |
Polish zloty |
3,8425 |
|
RON |
Romanian leu |
4,2525 |
|
TRY |
Turkish lira |
2,0377 |
|
AUD |
Australian dollar |
1,3098 |
|
CAD |
Canadian dollar |
1,2784 |
|
HKD |
Hong Kong dollar |
10,0858 |
|
NZD |
New Zealand dollar |
1,7113 |
|
SGD |
Singapore dollar |
1,6754 |
|
KRW |
South Korean won |
1 445,89 |
|
ZAR |
South African rand |
8,8815 |
|
CNY |
Chinese yuan renminbi |
8,5671 |
|
HRK |
Croatian kuna |
7,4015 |
|
IDR |
Indonesian rupiah |
11 715,84 |
|
MYR |
Malaysian ringgit |
3,9734 |
|
PHP |
Philippine peso |
57,017 |
|
RUB |
Russian rouble |
39,3615 |
|
THB |
Thai baht |
39,400 |
|
BRL |
Brazilian real |
2,1812 |
|
MXN |
Mexican peso |
15,6831 |
|
INR |
Indian rupee |
58,5050 |
(1) Source: reference exchange rate published by the ECB.
NOTICES FROM MEMBER STATES
|
13.1.2011 |
EN |
Official Journal of the European Union |
C 8/4 |
Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 1857/2006 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises active in the production of agricultural products and amending Regulation (EC) No 70/2001
2011/C 8/06
Aid No: XA 95/10
Member State: Spain
Region: Comunitat Valenciana
Title of aid scheme or name of company receiving an individual aid: Asociación de Usuarios de Casetas de Castellón
Legal basis: Resolución de 2010, de la Consellera de Agricultura, Pesca y Alimentación, por la que se concede una subvención nominativa a la Asociación de Usuarios de Casetas de Castellón.
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company: EUR 165 000 over the year 2010
Maximum aid intensity:
|
— |
100 %, (Article 16 1(d) of Regulation (EC) No 1857/2006), |
|
— |
50 % in less-favoured areas or 40 % in other regions (Article 2(a) and (b) of Regulation (EC) No 1857/2006). |
Date of implementation: From the date on which the identification number of the exemption request is published on the website of the Commission's Directorate-General for Agriculture and Rural Development
Duration of scheme or individual aid award: Throughout the year 2010
Objective of aid: Commission Regulation (EC) No 1857/2006 of 15 December 2006 on the application of Articles 87 and 88 of the EC Treaty on State aid to small and medium-sized enterprises active in the production of agricultural products and amending Regulation (EC) No 70/2001 (OJ L 358, 16.12.2006),
Article 16(1)(d)
Article 4(4)(a)
Sector(s) concerned: Owners of livestock holdings in the province of Castellón
Name and address of the granting authority:
|
Conselleria de Agricultura, Pesca y Alimentación |
|
C/ Amadeo de Saboya, 2 |
|
46010 Valencia |
|
ESPAÑA |
Website: http://www.agricultura.gva.es/web/c/document_library/get_file?uuid=d8311d4b-a36c-433f-b64e-1512cf00309f&groupId=16
Other information: —
Aid No: XA 178/10
Member State: Italy
Region: Marche
Title of aid scheme or name of company receiving an individual aid: aiuti per il pagamento dei premi assicurativi
Legal basis:
|
— |
Art. 2 comma 1 lettera a) della legge regionale 2 settembre 1997, n. 56 «Procedure relative agli aiuti compatibili con le disposizioni del Trattato di Roma con riguardo agli interventi straordinari nel settore agricolo» |
|
— |
DGR 2049 del 30 novembre 2009 ad oggetto: «Aiuti di Stato destinati ad ovviare e prevenire i danni arrecati dalle calamità naturali oppure da altri eventi» |
|
— |
DGR 1272 del 2 settembre 2010 ad oggetto «Modifica della DGR 2049 del 30 novembre 2009 Aiuti di stato destinati ad ovviare e prevenire i danni arrecati dalle calamità naturali oppure da altri eventi eccezionali [lr n. 56/97 art. 2 comma 1 lett. a)] — Indirizzi e criteri di erogazione». |
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company: The expenditure planned under this scheme will be determined annually on the basis of regional budget availability. Under the 2010 regional budget, EUR 308 065,93 is available. This amount constitutes the basis for expenditure over the coming years, subject to any decreases in the annual regional budget. Should it be necessary to exceed this basic amount of expenditure, a new aid request will submitted.
Beneficiaries:
Defence consortia and agricultural cooperatives and consortia authorised by the Marche Region within the meaning of Legislative Decree No 102/2004
Maximum aid intensity: Aid will be granted on the basis of the difference between the expenditure incurred by the Defence Organisations to pay for policies, as stipulated by Legislative Decree No 102/2004 as amended, and the maximum expenditure eligible for aid under the Annual Agricultural Insurance Plan, as stipulated in the opinion issued by the Region as specified in Article 13 of this Decree.
In accordance with Article 12 of Regulation (EC) No 1857/2006, gross aid intensity will not exceed:
|
— |
losses referred to in point (a) and against other losses caused by climatic events, and/or |
|
— |
losses caused by animal or plant diseases or pest infestations. |
The aid will not be limited to insurance provided by a single insurance company or group of companies, or be made subject to the condition that the insurance contract be taken out with a company established in Italy.
Date of implementation: From the date of publication of the identification number of the request for exemption on the website of the Commission’s Directorate-General for Agriculture and Rural Development
Duration of scheme or individual aid award: Under the scheme, aid may be granted until 31 December 2013 and for six months thereafter
Objective of aid: To encourage farmers to take out insurance against the risks of productions losses due to natural disasters, events assimilated to natural disasters, other disasters and losses caused by animal or plant diseases
Aid is granted on the basis of the provisions of Article 12 of Regulation (EC) No 1857/2006.
Sector(s) concerned: Agriculture — primary production
Name and address of the granting authority: Regione Marche — Giunta Regionale — Servizio Agricoltura, Forestazione e Pesca — PF Foreste e Irrigazione.
Website: http://www.agri.marche.it/Aree%20tematiche/Aiuti%20di%20stato/calamità2010.pdf
Other information: —
Il dirigente della pf foreste e irrigazione
Gabriella MASSACCESI
Aid No: XA 182/10
Member State: Federal Republic of Germany
Region: Niedersachsen
Title of aid scheme or name of company receiving an individual aid: Förderung nicht investiver Projekte im Bereich von landwirtschaftlichen Qualitätserzeugnissen aus ökologischem Landbau (VO (EG) Nr. 834/2007). Durchführung durch das Kompetenzzentrum Ökolandbau Niedersachsen (KÖN)
Legal basis: Landeshaushaltsordnung Niedersachsen
Erlass des Niedersächsischen Ministeriums für Ernährung, Landwirtschaft, Verbraucherschutz und Landesentwicklung (ML) vom 1. Juli 2010
Annual expenditure planned under the scheme or overall amount of individual aid granted to the company: The overall annual cost of the projects is expected to be approximately EUR 600 000.
Maximum aid intensity: Up to 100 % of the eligible costs
Date of implementation: Implementation from 2010 — support commencing 1 January 2011
Duration of scheme or individual aid award: End of scheme and last payment December 2013
Objective of aid: Non-investment support for quality products in accordance with Regulation (EC) No 834/2007 (organic farming). Implementation is by the KÖN. Recipients of the aid are small and medium-sized enterprises which are engaged in the primary production of agricultural products from organic farming or small and medium-sized enterprises which are engaged in the primary production of agricultural products and which intend to convert their production to organic farming.
The projects cover:
General observation of market developments in organic farming (Article 14(2)(a) of Regulation (EC) No 1857/2006)
Introduction of quality assurance schemes (Article 14(2)(b) of Regulation (EC) No 1857/2006)
Education and training of farmers as well as consultancy services which relate to organic farming or to conversion to organic farming and which do not constitute a continuous or periodic activity (Article 15(2)(a) and (c) of Regulation (EC) No 1857/2006)
Forums to share knowledge between businesses, exhibitions and fairs (Article 15(2)(d) of Regulation (EC) No 1857/2006)
Vulgarisation of scientific knowledge and provision of factual information on quality systems (Article 15(2)(e) of Regulation (EC) No 1857/2006)
Publications (Article 15(2)(f) of Regulation (EC) No 1857/2006).
Sector(s) concerned: The projects are intended to be multi-sectoral and to take into account as far as possible all economic operators involved in primary agricultural production.
Name and address of the granting authority:
|
Niedersächsisches Ministerium für Ernährung, Landwirtschaft, Verbraucherschutz und Landesentwicklung |
|
Calenberger Straße 2 |
|
30169 Hannover |
|
Referat 107.2 |
|
DEUTSCHLAND |
Website: http://www.ml.niedersachsen.de/live/live.php?navigation_id=26911&article_id=90411&_psmand=7
Other information: —
NOTICES CONCERNING THE EUROPEAN ECONOMIC AREA
Standing Committee of the EFTA States
|
13.1.2011 |
EN |
Official Journal of the European Union |
C 8/7 |
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2010
2011/C 8/07
Subcommittee I on the free movement of goods
To be noted by the EEA Joint Committee
With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2010, at their meeting on 1 October 2010:
|
Annex I |
List of new marketing authorisations |
|
Annex II |
List of renewed marketing authorisations |
|
Annex III |
List of extended marketing authorisations |
|
Annex IV |
List of withdrawn marketing authorisations |
|
Annex V |
List of suspended marketing authorisations |
ANNEX I
List of new marketing authorisations
The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2010:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/06/367/001/NO-012/NO |
Diacomit |
Norway |
5.2.2010 |
|
EU/1/08/476/005-006 |
Adcirca |
Liechtenstein |
28.2.2010 |
|
EU/1/09/571/001/IS |
Pandemic Influenza Vaccine H5N1 Baxter |
Iceland |
27.1.2010 |
|
EU/1/09/577/001/NO-004/NO |
Foclivia |
Norway |
18.2.2010 |
|
EU/1/09/583/001/NO-072/NO |
Irbesartan/Hydrochlorothiazide Teva |
Norway |
18.1.2010 |
|
EU/1/09/583/001-072 |
Irbesartan/Hydrochlorothiazide Teva |
Liechtenstein |
28.2.2010 |
|
EU/1/09/584/001-018 |
Sildenafil Teva |
Liechtenstein |
28.2.2010 |
|
EU/1/09/585/001/NO-018/NO |
Rivastigmine 1A |
Norway |
9.3.2010 |
|
EU/1/09/585/001-018/IS |
Rivastigmine 1A |
Iceland |
2.3.2010 |
|
EU/1/09/586/001/NO-010/NO |
Oslif Breezhaler |
Norway |
27.1.2010 |
|
EU/1/09/586/001-010 |
Oslif Breezhaler |
Liechtenstein |
28.2.2010 |
|
EU/1/09/587/001/NO-017/NO |
Olanzapine Glenmark |
Norway |
3.2.2010 |
|
EU/1/09/587/001-017 |
Olanzapine Glenmark |
Liechtenstein |
28.2.2010 |
|
EU/1/09/587/001-017/IS |
Olanzapine Glenmark |
Iceland |
25.1.2010 |
|
EU/1/09/588/001/NO-012/NO |
Olanzapine Glenmark Europe |
Norway |
6.2.2010 |
|
EU/1/09/588/001-012 |
Olanzapine Glenmark Europe |
Liechtenstein |
28.2.2010 |
|
EU/1/09/588/001-012/IS |
Olanzapine Glenmark Europe |
Iceland |
25.1.2010 |
|
EU/1/09/589/001/NO-018/NO |
Rivastigmine Hexal |
Norway |
9.3.2010 |
|
EU/1/09/589/001-018 |
Rivastigmine Hexal |
Liechtenstein |
28.2.2010 |
|
EU/1/09/589/001-018/IS |
Rivastigmine Hexal |
Iceland |
4.3.2010 |
|
EU/1/09/590/001/NO-006/NO |
Prevenar 13 |
Norway |
18.1.2010 |
|
EU/1/09/590/001-006 |
Prevenar 13 |
Liechtenstein |
28.2.2010 |
|
EU/1/09/592/001/NO-005/NO |
Olazax Disperzi |
Norway |
4.2.2010 |
|
EU/1/09/592/001-005 |
Olazax Disperzi |
Liechtenstein |
28.2.2010 |
|
EU/1/09/592/001-005/IS |
Olazax Disperzi |
Iceland |
25.1.2010 |
|
EU/1/09/593/001/NO-010/NO |
Onbrez Breezhaler |
Norway |
6.1.2010 |
|
EU/1/09/593/001-010 |
Onbrez Breezhaler |
Liechtenstein |
28.2.2010 |
|
EU/1/09/594/001/NO-010/NO |
Hirobriz Breezhaler |
Norway |
28.1.2010 |
|
EU/1/09/594/001-010 |
Hirobriz Breezhaler |
Liechtenstein |
28.2.2010 |
|
EU/1/09/595/001/NO-015/NO |
Sildenafil Actavis |
Norway |
13.1.2010 |
|
EU/1/09/595/001-015/IS |
Sildenafil Actavis |
Iceland |
7.1.2010 |
|
EU/1/09/596/001/NO-014/NO |
Lamuvidine Teva Pharma BV |
Norway |
11.1.2010 |
|
EU/1/09/596/001-014 |
Lamivudine Teva Pharma BV |
Liechtenstein |
28.2.2010 |
|
EU/1/09/596/001-014/IS |
Lamivudine Teva Pharma BV |
Iceland |
1.3.2010 |
|
EU/1/09/597/001/NO-005/NO |
Olazax |
Norway |
4.2.2010 |
|
EU/1/09/597/001-005/IS |
Olazax |
Iceland |
25.1.2010 |
|
EU/1/09/598/001/NO-004/NO |
Nevirapine Teva |
Norway |
11.1.2010 |
|
EU/1/09/598/001-004/IS |
Nevirapine Teva |
Iceland |
1.3.2010 |
|
EU/1/09/599/001/NO-018/NO |
Rivastigmine Sandoz |
Norway |
9.3.2010 |
|
EU/1/09/599/001-018/IS |
Rivastigmine Sandoz |
Iceland |
4.3.2010 |
|
EU/1/09/600/001/IS |
Zutectra |
Iceland |
24.2.2010 |
|
EU/1/09/600/001/NO |
Zutectra |
Norway |
11.1.2010 |
|
EU/1/09/601/001 |
Zenas |
Liechtenstein |
28.2.2010 |
|
EU/1/09/601/001/NO |
Zenas |
Norway |
4.2.2010 |
|
EU/1/09/601/001/IS |
Zenas |
Iceland |
20.1.2010 |
|
EU/1/09/602/001/NO-002/NO |
Scintimun |
Norway |
25.1.2010 |
|
EU/1/09/602/001-002 |
Scintimun |
Liechtenstein |
28.2.2010 |
|
EU/1/09/602/001-002/IS |
Scintimun |
Iceland |
21.1.2010 |
|
EU/1/09/603/001/NO-012/NO |
Sildenafil ratiopharm |
Norway |
13.1.2010 |
|
EU/1/09/603/001-012 |
Sildenafil ratiopharm |
Liechtenstein |
28.2.2010 |
|
EU/1/09/603/001-012/IS |
Sildenafil ratiopharm |
Iceland |
18.1.2010 |
|
EU/1/09/604/001/NO-010/NO |
Leflunomide Winthrop |
Norway |
4.2.2010 |
|
EU/1/09/604/001-010 |
Leflunomide Winthrop |
Liechtenstein |
28.2.2010 |
|
EU/1/09/604/001-010/IS |
Leflunomide Winthrop |
Iceland |
22.1.2010 |
|
EU/1/09/605/001-012 |
Temomedac |
Liechtenstein |
28.2.2010 |
|
EU/1/09/605/001-012/IS |
Temomedac |
Iceland |
24.2.2010 |
|
EU/1/09/606/001/NO-012/NO |
Temozolomide |
Norway |
15.2.2010 |
|
EU/1/09/606/001-012 |
Temozolomide |
Liechtenstein |
28.2.2010 |
|
EU/1/09/606/001-012/IS |
Temozolomide |
Iceland |
16.2.2010 |
|
EU/1/09/607/001/NO-014/NO |
Silodyx |
Norway |
9.2.2010 |
|
EU/1/09/607/001-014 |
Silodyx |
Liechtenstein |
28.2.2010 |
|
EU/1/09/607/001-014/IS |
Silodyx |
Iceland |
16.3.2010 |
|
EU/1/09/608/001/NO-014/NO |
Urorec |
Norway |
9.2.2010 |
|
EU/1/09/608/001-014 |
Urorec |
Liechtenstein |
28.2.2010 |
|
EU/1/09/608/001-014/IS |
Urorec |
Iceland |
16.3.2010 |
|
EU/1/09/609/001/NO-002/NO |
Elonva |
Norway |
11.3.2010 |
|
EU/1/09/609/001-002 |
Elonva |
Liechtenstein |
28.2.2010 |
|
EU/1/09/609/001-002/IS |
Elonva |
Iceland |
10.2.2010 |
|
EU/1/09/610/001/NO-030/NO |
Telmisartan Teva |
Norway |
2.3.2010 |
|
EU/1/09/610/001-030 |
Telmisartan Teva |
Liechtenstein |
28.2.2010 |
|
EU/1/09/610/001-030/IS |
Telmisartan Teva |
Iceland |
16.3.2010 |
|
EU/1/09/611/001/NO-002/NO |
Docetaxel Teva |
Norway |
26.2.2010 |
|
EU/1/09/611/001-002 |
Docetaxel Teva |
Liechtenstein |
28.2.2010 |
|
EU/1/09/611/001-002/IS |
Docetaxel Teva |
Iceland |
23.2.2010 |
|
EU/1/10/612/001/NO-006/NO |
Revolade |
Norway |
25.3.2010 |
|
EU/1/10/612/001-006 |
Revolade |
Liechtenstein |
30.4.2010 |
|
EU/1/10/612/001-006/IS |
Revolade |
Iceland |
7.4.2010 |
|
EU/1/10/613/001/NO-002/NO |
ImmunoGam |
Norway |
19.4.2010 |
|
EU/1/10/613/001-002 |
ImmunoGam |
Liechtenstein |
30.4.2010 |
|
EU/1/10/613/001-002/IS |
ImmunoGam |
Iceland |
28.4.2010 |
|
EU/1/10/614/001 |
Menveo |
Liechtenstein |
30.4.2010 |
|
EU/1/10/614/001/IS |
Menveo |
Iceland |
15.6.2010 |
|
EU/1/10/614/001/NO |
Menveo |
Norway |
21.4.2010 |
|
EU/1/10/615/001/NO-024/NO |
Temozolomide Hospira |
Norway |
24.3.2010 |
|
EU/1/10/615/001-024 |
Temozolomide Hospira |
Liechtenstein |
30.4.2010 |
|
EU/1/10/615/001-024/IS |
Temozolomide Hospira |
Iceland |
3.5.2010 |
|
EU/1/10/616/001/NO-024/NO |
Temozolomide Hexal |
Norway |
26.4.2010 |
|
EU/1/10/616/001-024 |
Temozolomide Hexal |
Liechtenstein |
30.4.2010 |
|
EU/1/10/616/001-024/IS |
Temozolomide Hexal |
Iceland |
27.4.2010 |
|
EU/1/10/617/001/NO-024/NO |
Temozolomide Sandoz |
Norway |
26.4.2010 |
|
EU/1/10/617/001-024 |
Temozolomide Sandoz |
Liechtenstein |
30.4.2010 |
|
EU/1/10/617/001-024/IS |
Temozolomide Sandoz |
Iceland |
27.4.2010 |
|
EU/1/10/618/001-004 |
Prolia |
Liechtenstein |
30.6.2010 |
|
EU/1/10/618/001-004/IS |
Prolia |
Iceland |
23.6.2010 |
|
EU/1/10/619/001/NO-014/NO |
DuoPlavin |
Norway |
23.3.2010 |
|
EU/1/10/619/001-014 |
DuoPlavin |
Liechtenstein |
30.4.2010 |
|
EU/1/10/619/001-014/IS |
DuoPlavin |
Iceland |
21.4.2010 |
|
EU/1/10/620/001/NO-016/NO |
Ristfor |
Norway |
3.6.2010 |
|
EU/1/10/620/001-016 |
Ristfor |
Liechtenstein |
30.4.2010 |
|
EU/1/10/620/001-016/IS |
Ristfor |
Iceland |
5.5.2010 |
|
EU/1/10/621/001/NO-018/NO |
Ristaben |
Norway |
3.6.2010 |
|
EU/1/10/621/001-018 |
Ristaben |
Liechtenstein |
30.4.2010 |
|
EU/1/10/621/001-018/IS |
Ristaben |
Iceland |
5.5.2010 |
|
EU/1/10/622/001/NO-002/NO |
Tepadina |
Norway |
25.3.2010 |
|
EU/1/10/622/001-002/IS |
Tepadina |
Iceland |
21.4.2010 |
|
EU/1/10/622/001-002 |
Tepadina |
Liechtenstein |
30.4.2010 |
|
EU/1/10/623/001/NO-014/NO |
DuoCover |
Norway |
23.3.2010 |
|
EU/1/10/623/001-014 |
DuoCover |
Liechtenstein |
30.4.2010 |
|
EU/1/10/623/001-014/IS |
DuoCover |
Iceland |
21.4.2010 |
|
EU/1/10/624/001 |
Arepanrix |
Liechtenstein |
30.4.2010 |
|
EU/1/10/624/001/IS |
Arepanrix |
Iceland |
21.5.2010 |
|
EU/1/10/625/001/NO-002/NO |
Arzerra |
Norway |
12.5.2010 |
|
EU/1/10/625/001-002 |
Arzerra |
Liechtenstein |
30.4.2010 |
|
EU/1/10/625/001-002/IS |
Arzerra |
Iceland |
17.5.2010 |
|
EU/1/10/626/001/NO-004/NO |
Ribavirin BioPartners |
Norway |
22.4.2010 |
|
EU/1/10/626/001-004/IS |
Ribavirin BioPartners |
Iceland |
17.5.2010 |
|
EU/1/10/627/001/NO-003/NO |
Raloxifene Teva |
Norway |
31.5.2010 |
|
EU/1/10/627/001-003 |
Raloxifene Teva |
Liechtenstein |
30.4.2010 |
|
EU/1/10/627/001-003/IS |
Raloxifene Teva |
Iceland |
18.6.2010 |
|
EU/1/10/628/001/NO-004/NO |
Votrient |
Norway |
28.6.2010 |
|
EU/1/10/628/001-004 |
Votrient |
Liechtenstein |
30.6.2010 |
|
EU/1/10/628/001-004/IS |
Votrient |
Iceland |
28.6.2010 |
|
EU/1/10/629/001 |
Humenza |
Liechtenstein |
30.6.2010 |
|
EU/1/10/629/001/IS |
Humenza |
Iceland |
28.6.2010 |
|
EU/1/10/630/001/NO-002/NO |
Docefrez |
Norway |
7.6.2010 |
|
EU/1/10/630/001-002 |
Docefrez |
Liechtenstein |
30.6.2010 |
|
EU/1/10/630/001-002/IS |
Docefrez |
Iceland |
29.6.2010 |
|
EU/1/10/631/001-009 |
Nivestim |
Liechtenstein |
30.6.2010 |
|
EU/1/10/632/001-021 |
Tolura |
Liechtenstein |
30.6.2010 |
|
EU/1/10/633/001/NO-002/NO |
Topotecan Hospira |
Norway |
22.6.2010 |
|
EU/1/10/633/001-002 |
Topotecan Hospira |
Liechtenstein |
30.6.2010 |
|
EU/1/10/634/001-004 |
Ribaverin Three Rivers |
Liechtenstein |
30.6.2010 |
|
EU/1/10/634/001-004/IS |
Ribavirin Three Rivers |
Iceland |
28.6.2010 |
|
EU/1/10/635/001-014 |
Olanzapine Apotex |
Liechtenstein |
30.6.2010 |
|
EU/1/10/635/001-014/IS |
Olanzapine Apotex |
Iceland |
28.6.2010 |
|
EU/2/08/085/001/NO |
Easotic |
Norway |
4.5.2010 |
|
EU/2/08/090/001-008/IS |
Loxicom |
Iceland |
23.2.2010 |
|
EU/2/09/096/001/NO-002/NO |
Leucogen |
Norway |
8.2.2010 |
|
EU/2/09/101/001/NO-010/NO |
Zolvix |
Norway |
8.2.2010 |
|
EU/2/09/101/001-010/IS |
Zolvix |
Iceland |
4.3.2010 |
|
EU/2/09/102/001/NO-006/NO |
Gripovac 3 |
Norway |
21.4.2010 |
|
EU/2/09/102/001-006 |
Gripovac 3 |
Liechtenstein |
28.2.2010 |
|
EU/2/09/102/001-006/IS |
Gripovac 3 |
Iceland |
4.3.2010 |
|
EU/2/09/103/001-006 |
Respiporc FLU3 |
Liechtenstein |
28.2.2010 |
|
EU/2/09/103/001-006/IS |
Respiporc FLU3 |
Iceland |
4.3.2010 |
|
EU/2/09/104/001/NO-002/NO |
Zulvac 8 Ovis |
Norway |
11.2.2010 |
|
EU/2/09/104/001-002 |
Zulvac 8 Ovis |
Liechtenstein |
28.2.2010 |
|
EU/2/09/104/001-002/IS |
Zulvac 8 Ovis |
Iceland |
28.1.2010 |
|
EU/2/09/105/001/NO-002/NO |
Zulvac 8 Bovis |
Norway |
8.2.2010 |
|
EU/2/09/105/001-002 |
Zulvac 8 Bovis |
Liechtenstein |
28.2.2010 |
|
EU/2/09/105/001-002/IS |
Zulvac 8 Bovis |
Iceland |
27.1.2010 |
ANNEX II
List of renewed marketing authorisations
The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2010:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/00/129/001-003 |
Azopt |
Liechtenstein |
28.2.2010 |
|
EU/1/00/129/001-003/IS |
Azopt |
Iceland |
16.3.2010 |
|
EU/1/00/130/001/NO-002/NO |
Orgalutran |
Norway |
8.6.2010 |
|
EU/1/00/130/001-002 |
Orgalutran |
Liechtenstein |
30.6.2010 |
|
EU/1/00/130/001-002/IS |
Orgalutran |
Iceland |
25.6.2010 |
|
EU/1/00/131/001/NO-005/NO |
PegIntron |
Norway |
26.5.2010 |
|
EU/1/00/131/001-050 |
PegIntron |
Liechtenstein |
30.6.2010 |
|
EU/1/00/131/001-050/IS |
PegIntron |
Iceland |
24.6.2010 |
|
EU/1/00/132/001/NO-050/NO |
ViraferonPeg |
Norway |
26.5.2010 |
|
EU/1/00/132/001-050 |
ViraferonPeg |
Liechtenstein |
30.6.2010 |
|
EU/1/00/132/001-050/IS |
ViraferonPeg |
Iceland |
25.6.2010 |
|
EU/1/00/133/001/NO-032/NO |
Optisulin |
Norway |
25.5.2010 |
|
EU/1/00/133/001-032 |
Optisulin |
Liechtenstein |
30.6.2010 |
|
EU/1/00/133/001-032/IS |
Optisulin |
Iceland |
25.6.2010 |
|
EU/1/00/134/001/NO-037/NO |
Lantus |
Norway |
25.5.2010 |
|
EU/1/00/134/001-037 |
Lantus |
Liechtenstein |
30.6.2010 |
|
EU/1/00/134/001-037/IS |
Lantus |
Iceland |
25.6.2010 |
|
EU/1/00/137/002/NO-018/NO |
Avandia |
Norway |
7.6.2010 |
|
EU/1/00/137/002-012/IS |
Avandia |
Iceland |
18.6.2010 |
|
EU/1/00/137/002-018 |
Avandia |
Liechtenstein |
30.6.2010 |
|
EU/1/00/140/001 |
Visudyne |
Liechtenstein |
30.6.2010 |
|
EU/1/00/140/001/IS |
Visudyne |
Iceland |
23.6.2010 |
|
EU/1/04/272/001/NO-002/NO |
PhotoBarr |
Norway |
17.2.2010 |
|
EU/1/04/294/001-028 |
Emselex |
Liechtenstein |
28.2.2010 |
|
EU/1/04/298/001/NO-003/NO |
Kivexa |
Norway |
19.1.2010 |
|
EU/1/04/298/001-003 |
Kivexa |
Liechtenstein |
28.2.2010 |
|
EU/1/04/299/001/NO-003/NO |
Fendrix |
Norway |
3.2.2010 |
|
EU/1/04/299/001-003 |
Fendrix |
Liechtenstein |
28.2.2010 |
|
EU/1/04/299/001-003/IS |
Fendrix |
Iceland |
7.1.2010 |
|
EU/1/04/300/001/NO-002/NO |
Avastin |
Norway |
26.1.2010 |
|
EU/1/04/300/001-002 |
Avastin |
Liechtenstein |
28.2.2010 |
|
EU/1/04/300/001-002/IS |
Avastin |
Iceland |
11.1.2010 |
|
EU/1/04/302/001/NO-004/NO |
Prialt |
Norway |
8.2.2010 |
|
EU/1/04/302/001-004 |
Prialt |
Liechtenstein |
28.2.2010 |
|
EU/1/04/302/001-004/IS |
Prialt |
Iceland |
17.3.2010 |
|
EU/1/04/303/001/NO-003 |
Orfadin |
Norway |
3.2.2010 |
|
EU/1/04/303/001-003 |
Orfadin |
Liechtenstein |
28.2.2010 |
|
EU/1/04/303/001-003/IS |
Orfadin |
Iceland |
28.1.2010 |
|
EU/1/04/304/001/NO-007/NO |
Azilect |
Norway |
10.2.2010 |
|
EU/1/04/305/001/NO-002/NO |
Truvada |
Norway |
3.2.2010 |
|
EU/1/04/305/001-002 |
Truveda |
Liechtenstein |
28.2.2010 |
|
EU/1/04/305/001-002/IS |
Truvada |
Iceland |
28.1.2010 |
|
EU/1/04/306/001 |
Aloxi |
Liechtenstein |
30.4.2010 |
|
EU/1/04/306/001/IS |
Aloxi |
Iceland |
11.5.2010 |
|
EU/1/04/306/01/NO |
Aloxi |
Norway |
23.4.2010 |
|
EU/1/04/307/001/NO-013/NO |
Zonegran |
Norway |
5.2.2010 |
|
EU/1/04/307/001-013 |
Zonegran |
Liechtenstein |
28.2.2010 |
|
EU/1/04/307/001-013/IS |
Zonegran |
Iceland |
13.1.2010 |
|
EU/1/05/308/001/NO-002/NO |
Aclasta |
Norway |
23.4.2010 |
|
EU/1/05/308/001-002 |
Aclasta |
Liechtenstein |
30.4.2010 |
|
EU/1/05/308/001-002/IS |
Aclasta |
Iceland |
30.4.2010 |
|
EU/1/06/367/001-012 |
Diacomit |
Liechtenstein |
28.2.2010 |
|
EU/1/07/423/001-003 |
Vectibix |
Liechtenstein |
30.4.2010 |
|
EU/1/07/423/001-003/IS |
Vectibix |
Iceland |
7.4.2010 |
|
EU/1/07/440/001-003/IS |
Tyverb |
Iceland |
30.6.2010 |
|
EU/1/10/618/001/NO-004/NO |
Prolia |
Norway |
14.6.2010 |
|
EU/1/99/122/001-002 |
Thyrogen |
Liechtenstein |
28.2.2010 |
|
EU/1/99/122/001-002/IS |
Thyrogen |
Iceland |
19.2.2010 |
|
EU/1/99/123/005/NO-013/NO |
Renagel |
Norway |
14.1.2010 |
|
EU/1/99/123/005-013 |
Renagel |
Liechtenstein |
28.2.2010 |
|
EU/1/99/123/005-013/IS |
Renagel |
Iceland |
5.1.2010 |
|
EU/1/99/124/001/NO-002/NO |
Tractocile |
Norway |
27.1.2010 |
|
EU/1/99/124/001-002 |
Tractocile |
Liechtenstein |
28.2.2010 |
|
EU/1/99/124/001-002/IS |
Tractocile |
Iceland |
18.1.2010 |
|
EU/1/99/126/001/NO-021/NO |
Enbrel |
Norway |
14.1.2010 |
|
EU/1/99/127/011/NO-044/NO |
IntronA |
Norway |
21.4.2010 |
|
EU/1/99/127/011-039 & 041-044/IS |
IntronA |
Iceland |
19.4.2010 |
|
EU/1/99/127/011-044 |
IntronA |
Liechtenstein |
30.4.2010 |
|
EU/2/00/018/001 |
Incurin |
Liechtenstein |
30.4.2010 |
|
EU/2/00/018/001/IS |
Incurin |
Iceland |
21.4.2010 |
|
EU/2/00/018/001/NO |
Incurin |
Norway |
10.5.2010 |
|
EU/2/00/019/005/NO-007/NO |
Purevax FeLV |
Norway |
10.5.2010 |
|
EU/2/00/019/005-007 |
Purevax FeLV |
Liechtenstein |
30.4.2010 |
|
EU/2/00/019/005-007/IS |
Purevax FeLV |
Iceland |
10.5.2010 |
|
EU/2/00/021/001-002 |
Rabigen SAG2 |
Liechtenstein |
30.4.2010 |
|
EU/2/00/021/001-002/IS |
Rabigen SAG2 |
Iceland |
5.5.2010 |
|
EU/2/00/022/001a-001b, EU/2/00/022/002a-002b, EU/2/00/022/003a-003b, EU/2/022/004a-004b, EU/2/00/022/005-017 |
Ibaflin |
Liechtenstein |
30.6.2010 |
|
EU/2/00/022/003-004 a+b&007-008/IS |
Ibaflin |
Iceland |
22.6.2010 |
|
EU/2/00/022/001-002 a+b&005-006/IS |
Ibaflin |
Iceland |
22.6.2010 |
|
EU/2/00/22/009-017/IS |
Ibaflin |
Iceland |
22.6.2010 |
|
EU/2/04/043/001/IS |
Equilis StrepE |
Iceland |
14.4.2010 |
|
EU/2/04/047/001/NO-002/NO |
Purevax RCPCh FeLV |
Norway |
24.2.2010 |
|
EU/2/04/047/001-002 |
Purevax RCPCh FeLV |
Liechtenstein |
28.2.2010 |
|
EU/2/04/047/001-002/IS |
Purevax RCPCh FeLV |
Iceland |
15.1.2010 |
|
EU/2/04/048/001-002 |
Purevax RCP FeLV |
Liechtenstein |
28.2.2010 |
|
EU/2/04/048/001-002/IS |
Purevax RCP FeLV |
Iceland |
9.2.2010 |
|
EU/2/04/049/001-002 |
Purevax RCCh |
Liechtenstein |
28.2.2010 |
|
EU/2/04/049/001-002/IS |
Purevax RCCh |
Iceland |
9.2.2010 |
|
EU/2/04/051/001-002 |
Purevax RC |
Liechtenstein |
28.2.2010 |
|
EU/2/04/051/001-002/IS |
Purevax RC |
Iceland |
9.2.2010 |
|
EU/2/04/052/001-002/IS |
Purevax RCP |
Iceland |
9.2.2010 |
|
EU/2/04/50/001-002/IS |
Purevax RCPCh |
Iceland |
8.2.2010 |
|
EU/2/05/053/001-003 |
Naxcel |
Liechtenstein |
30.6.2010 |
|
EU/2/99/013/001/NO-002/NO |
Halocur |
Norway |
26.4.2010 |
|
EU/2/99/013/001-002/IS |
Halocur |
Iceland |
15.3.2010 |
|
EU/2/99/017/001/NO-006/NO |
Ibraxion |
Norway |
11.5.2010 |
|
EU/2/99/017/001-006/IS |
Ibraxion |
Iceland |
25.5.2010 |
ANNEX III
List of extended marketing authorisations
The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2010:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/00/152/019-020 |
Infanrix hexa |
Liechtenstein |
30.6.2010 |
|
EU/1/00/156/004 |
Trizivir |
Liechtenstein |
30.6.2010 |
|
EU/1/01/172/007 |
Kaletra |
Liechtenstein |
28.2.2010 |
|
EU/1/02/205/003/NO-004/NO |
Lumigan |
Norway |
12.3.2010 |
|
EU/1/02/205/003-004 |
Lumigan |
Liechtenstein |
28.2.2010 |
|
EU/1/02/205/003-004/IS |
Lumigan |
Iceland |
21.1.2010 |
|
EU/1/04/278/010-011 |
Levemir |
Liechtenstein |
30.4.2010 |
|
EU/1/04/306/002-003 |
Aloxi |
Liechtenstein |
30.6.2010 |
|
EU/1/04/306/002-003/IS |
Aloxi |
Iceland |
11.5.2010 |
|
EU/1/05/318/002 |
Revatio |
Liechtenstein |
28.2.2010 |
|
EU/1/05/318/002/IS |
Revatio |
Iceland |
14.1.2010 |
|
EU/1/05/318/002/NO |
Revatio |
Norway |
18.1.2010 |
|
EU/1/05/329/006 |
Kiovig |
Liechtenstein |
30.6.2010 |
|
EU/1/06/334/005 |
Evoltra |
Liechtenstein |
28.2.2010 |
|
EU/1/06/360/013 |
Champix |
Liechtenstein |
28.2.2010 |
|
EU/1/07/384/003/NO-004/NO |
Docetaxel Winthrop |
Norway |
1.2.2010 |
|
EU/1/07/384/003-004 |
Docetaxel Winthrop |
Liechtenstein |
28.2.2010 |
|
EU/1/07/384/005 |
Docetaxel Winthrop |
Liechtenstein |
30.6.2010 |
|
EU/1/07/386/017-018 |
Toviaz |
Liechtenstein |
28.2.2010 |
|
EU/1/07/400/022-024 |
Mircera |
Liechtenstein |
30.4.2010 |
|
EU/1/07/405/021-040 |
Rasilez |
Liechtenstein |
28.2.2010 |
|
EU/1/07/411/021-026/IS |
Epoetin alfa Hexal |
Iceland |
3.2.2010 |
|
EU/1/07/412/021/NO-026/NO |
Abseamed |
Norway |
13.1.2010 |
|
EU/1/07/412/021-026 |
Abseamed |
Liechtenstein |
28.2.2010 |
|
EU/1/07/440/003 |
Tyverb |
Liechtenstein |
30.6.2010 |
|
EU/1/08/444/009-012 |
Ratiograstim |
Liechtenstein |
28.2.2010 |
|
EU/1/08/445/009-014 |
Tevagrastim |
Liechtenstein |
28.2.2010 |
|
EU/1/08/450/009-010 |
Biograstim |
Liechtenstein |
28.2.2010 |
|
EU/1/08/453/002/NO |
Prepandrix |
Norway |
9.2.2010 |
|
EU/1/08/467/002 |
Doribax |
Liechtenstein |
30.4.2010 |
|
EU/1/08/467/002/IS |
Doribax |
Iceland |
15.6.2010 |
|
EU/1/08/494/003-004 |
Stelara |
Liechtenstein |
30.4.2010 |
|
EU/1/08/497/005/NO-008/NO |
Nplate |
Norway |
2.2.2010 |
|
EU/1/08/497/005-008 |
Nplate |
Liechtenstein |
28.2.2010 |
|
EU/1/08/497/005-008/IS |
Nplate |
Iceland |
22.1.2010 |
|
EU/1/09/508/010 |
Synflorix |
Liechtenstein |
28.2.2010 |
|
EU/1/09/525/047-050 |
Nimvastid |
Liechtenstein |
30.4.2010 |
|
EU/1/09/526/002 |
Iressa |
Liechtenstein |
28.2.2010 |
|
EU/1/09/528/002 |
Nymusa |
Liechtenstein |
30.6.2010 |
|
EU/1/09/538/007-008 |
Afinitor |
Liechtenstein |
30.4.2010 |
|
EU/1/09/540/010-016 |
Clopidogrel Teva |
Liechtenstein |
30.4.2010 |
|
EU/1/09/556/010-011 |
Clopidogrel Krka |
Liechtenstein |
30.4.2010 |
|
EU/1/09/557/010 |
Clopidogrel Qualimed |
Liechtenstein |
30.4.2010 |
|
EU/1/09/559/010-016 |
Clopidogrel Mylan |
Liechtenstein |
30.4.2010 |
|
EU/1/95/002/003/NO-004/NO |
Taxotere |
Norway |
25.1.2010 |
|
EU/1/95/002/003-004 |
Taxotere |
Liechtenstein |
28.2.2010 |
|
EU/1/95/002/005 |
Taxotere |
Liechtenstein |
30.6.2010 |
|
EU/1/96/016/005/NO-006/NO |
Norvir |
Norway |
9.2.2010 |
|
EU/1/96/016/005-006 |
Norvir |
Liechtenstein |
28.2.2010 |
|
EU/1/96/016/005-006/IS |
Norvir |
Iceland |
12.2.2010 |
|
EU/1/97/050/028-033 |
Sifrol |
Liechtenstein |
30.6.2010 |
|
EU/1/98/069/012 |
Plavix |
Liechtenstein |
30.4.2010 |
|
EU/1/98/070/012 |
Iscover |
Liechtenstein |
30.4.2010 |
|
EU/1/98/080/002 |
Aldara |
Liechtenstein |
30.4.2010 |
|
EU/1/98/096/024-025 |
Temodal |
Liechtenstein |
28.2.2010 |
|
EU/1/97/051/028-033 |
Mirapexin |
Liechtenstein |
30.6.2010 |
|
EU/2/02/032/002 |
Vaxxitek HVT+IBD |
Liechtenstein |
30.6.2010 |
|
EU/2/04/044/011/NO-013/NO |
Aivlosin |
Norway |
29.4.2010 |
|
EU/2/04/044/011-013 |
Aivlosin |
Liechtenstein |
28.2.2010 |
|
EU/2/04/044/011-013/IS |
Aivlosin |
Iceland |
7.1.2010 |
|
EU/2/06/070/004/IS |
Meloxidyl |
Iceland |
25.1.2010 |
|
EU/2/06/070/005-007 |
Meloxidyl |
Liechtenstein |
30.4.2010 |
|
EU/2/08/083/002-003 |
Equioxx |
Liechtenstein |
28.2.2010 |
|
EU/2/08/083/002-003/IS |
Equioxx |
Iceland |
11.1.2010 |
|
EU/2/08/089/021 |
Onsior |
Liechtenstein |
28.2.2010 |
|
EU/2/08/090/009 |
Loxicom |
Liechtenstein |
30.4.2010 |
|
EU/2/97/004/035-038 |
Metacam |
Liechtenstein |
28.2.2010 |
ANNEX IV
List of withdrawn marketing authorisations
The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2010:
|
EU-Number |
Product |
Country |
Date of withdrawal |
|
EU/1/00/148/001-004 |
Agenerase |
Liechtenstein |
30.6.2010 |
|
EU/1/00/148/001-004/IS |
Agenerase |
Iceland |
29.6.2010 |
|
EU/1/06/375/001-033 |
Irbesartan BMS |
Liechtenstein |
28.2.2010 |
|
EU/1/08/471/001-012/IS |
Duloxetine Boehringer Ingelheim |
Iceland |
25.6.2010 |
|
EU/1/08/471/003-005, 011-012 |
Duloxetine Boehringer Ingelheim |
Liechtenstein |
30.6.2010 |
|
EU/1/99/113/001-004 |
Paxene |
Liechtenstein |
28.2.2010 |
ANNEX V
List of suspended marketing authorisations
The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2010:
|
EU-Number |
Product |
Country |
Date of suspension |
|
EU/1/09/532/001-007 |
Clopidogrel Acino |
Liechtenstein |
30.4.2010 |
|
EU/1/09/532/001-007/IS |
Clopidogrel Acino |
Iceland |
30.4.2010 |
|
EU/1/09/534/001-007 |
Clopidogrel Hexal |
Liechtenstein |
30.4.2010 |
|
EU/1/09/534/001-007 |
Clopidogrel Sandoz |
Liechtenstein |
30.4.2010 |
|
EU/1/09/534/001-007/IS |
Clopidogrel Hexal |
Iceland |
30.4.2010 |
|
EU/1/09/541/001-007/IS |
Clopidogrel ratiopharm GmbH |
Iceland |
30.4.2010 |
|
EU/1/09/541/001-008 |
Clopidogrel ratiopharm GmbH |
Liechtenstein |
30.4.2010 |
|
EU/1/09/542/001-007 |
Clopidogrel 1A Pharma |
Liechtenstein |
30.4.2010 |
|
EU/1/09/542/001-007/IS |
Clopidogrel 1A Pharma |
Iceland |
30.4.2010 |
|
EU/1/09/547/001-007/IS |
Clopidogrel Sandoz |
Iceland |
30.4.2010 |
|
EU/1/09/548/001-007 |
Clopidogrel Acino Pharma GmbH |
Liechtenstein |
30.4.2010 |
|
EU/1/09/548/001-007/IS |
Clopidogrel Acino Pharma GmbH |
Iceland |
30.4.2010 |
|
EU/1/09/554/001-007/IS |
Clopidogrel ratiopharm |
Iceland |
30.4.2010 |
|
EU/1/09/554/001-008 |
Clopidogrel ratiopharm |
Liechtenstein |
30.4.2010 |
V Announcements
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY
European Commission
|
13.1.2011 |
EN |
Official Journal of the European Union |
C 8/20 |
Initiation of proceedings
(Case COMP/M.5907 — Votorantim/Fischer/JV)
(Text with EEA relevance)
2011/C 8/08
On 7 January 2011, the Commission decided to initiate proceedings in the above mentioned case after finding that the notified concentration raises serious doubts as to its compatibility with the common market. The initiation of proceedings opens a second phase investigation with regard to the notified concentration, and is without prejudice to the final decision on the case. The decision is based on Article 6(1)(c) of Council Regulation (EC) No 139/2004.
The Commission invites interested third parties to submit their observations on the proposed concentration to the Commission.
In order to be fully taken into account in the procedure, observations should reach the Commission not later than 15 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301 / 2967244) or by post, under reference COMP/M.5907 — Votorantim/Fischer/JV, to the following address:
|
European Commission |
|
Directorate-General for Competition |
|
Merger Registry |
|
J-70 |
|
1049 Bruxelles/Brussel |
|
BELGIQUE/BELGIË |